Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.
about
Amyloid-associated depression: a prodromal depression of Alzheimer disease?Effect of Anticoagulants on Amyloid β-Protein Precursor and Amyloid Beta Levels in Plasma.Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseReversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO miceAbnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease.Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Plasma ß-amyloid and cognitive decline.Identifying and validating biomarkers for Alzheimer's disease.Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway.Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.Amyloid-β induces hepatic insulin resistance in vivo via JAK2.A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer diseasePeripheral Abeta subspecies as risk biomarkers of Alzheimer's diseaseMaximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.Alzheimer's disease in Down syndrome: neurobiology and risk.Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndromePlasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerMultiplex biomarkers in blood.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome.Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease.Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Biomarkers in Sporadic and Familial Alzheimer's Disease.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community.Serum beta-amyloid correlates with neuropsychological impairment.Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.Relation of plasma homocysteine to plasma amyloid beta levels.Association between the characteristics of metabolic syndrome and Alzheimer's disease.Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.
P2860
Q22253023-B6CAD8F5-E342-40AC-871C-318C7B0E43B2Q24303677-6E1705E6-E670-4FCB-9F54-24FCFE82C412Q27027319-B7751421-5255-4919-B247-6760D192780FQ30473360-9FCB2690-AAF6-448D-9CE2-CDCE4C6EB79EQ33854028-A20B264E-1F42-44F7-9F7B-3AC740ED1BA0Q34056793-380177DE-E46B-48DC-8486-B25D197BE44EQ34292024-D02DC322-6C0B-47C6-B18F-DD3AC118D514Q34424794-B85A5776-9A4E-4C85-98DC-8A459F695747Q34468961-E14CCB39-CE35-48FB-BAF2-B65BA989DB42Q35601036-30B9E345-0394-4BA2-AFE1-67A9863FF350Q35976702-81F9CE8F-2D26-444F-938E-8941C7411EA5Q36064807-93035EED-812C-4866-9E7E-6BB8376A71C9Q36200059-45AF35E6-5ADA-4E96-BA01-74DE8C4337BAQ36265279-F64DE323-A7EA-46E8-AE6B-5045B5E23BC4Q36720621-B0D56002-6621-4531-8586-EBBFF37F4644Q36746432-57588BA9-9542-43FF-B4DE-17052C18DCB8Q36893677-B14FB521-19A1-482B-8709-4210E6B77B8FQ36919081-E25B0B73-D538-4FE2-977A-D210B41FC80DQ36957698-EAFD0D84-AB8A-40DD-B320-8903FE4C9934Q36983170-88F09C41-D064-40DB-B638-1AC90C8A956AQ36998414-BE59D109-4DFF-4388-A3F8-0A255131C1B2Q36998638-1CB22EBA-656F-471F-8D79-E4DD69F1F621Q37118083-B6E8507E-8F2D-4246-9E9E-34B9BBFF94BBQ37143598-0DBE8F34-D016-40FB-B5F0-C20219793FE9Q37455779-F6A8D1A7-614E-40A3-B4F9-FE623595B5BEQ37665855-AA0A01B9-FA86-43A3-BC79-7CF61CC1AA0EQ37715542-995867F9-640E-4B27-A2AC-5D92D3A4CE61Q38037157-B778EB46-9E26-4BF2-8575-E1FF007D7E5BQ38038399-4138363E-77E5-4E50-8E6D-0711C062B446Q38222874-605FCDAC-4E3A-4C69-928A-AA9FC48CB867Q38592041-C168DAA5-672A-4E71-B970-829638B06E22Q39348762-E3E27379-C02B-45E0-AD4C-8A9E39BD6FECQ39978914-A93E949D-3F56-4A68-B36F-4DBB5B8D4CF2Q43478841-4F06FA1E-A4A2-4789-A0F3-ECE4CE074423Q44917427-BFF3BADF-9945-4CAC-BBD1-B7C3C7B96EFFQ48326897-9CE5C4F2-22CE-4F89-BCB8-EC6E1332E669Q51018894-73C84137-49EC-478B-8778-B2EEE585F0D7Q52035993-B6F2DBED-08CF-4844-9680-F090C56D8265
P2860
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@en
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@nl
type
label
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@en
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@nl
prefLabel
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@en
Plasma levels of amyloid beta- ...... ith mild cognitive impairment.
@nl
P2093
P1433
P1476
Plasma levels of amyloid beta- ...... with mild cognitive impairment
@en
P2093
F Dagna-Bricarelli
L Giliberto
M L Inglese
P304
P356
10.1212/01.WNL.0000137040.64252.ED
P407
P577
2004-09-01T00:00:00Z